Created at Source Raw Value Validated value
Oct. 26, 2020, 11:31 p.m. usa

[{"arm_notes": "nan", "treatment_id": 1182, "treatment_name": "Selinexor", "treatment_type": "Others pharmacological treatment", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": 1182, "treatment_name": "Selinexor", "treatment_type": "Others pharmacological treatment", "pharmacological_treatment": "Pharmacological treatment"}]

[{"arm_notes": "40 milligram (mg) on Days 1 and 3 of each week for up to 2 weeks (14 days). If the participant is tolerating therapy and clinically benefitting, dosing can continue for an additional 2 weeks (28 days). If the participant is tolerating therapy and clinically benefitting, dosing can continue for an additional 2 weeks (28 days).", "treatment_id": 1182, "treatment_name": "Selinexor", "treatment_type": "Others pharmacological treatment", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "20 milligram (mg) on Days 1, 3 and 5 of each week for up to 2 weeks (14 days). If the participant is tolerating therapy and clinically benefitting, dosing can continue for an additional 2 weeks (28 days).", "treatment_id": 1182, "treatment_name": "Selinexor", "treatment_type": "Others pharmacological treatment", "pharmacological_treatment": "Pharmacological treatment"}]